Genetic epilepsy with febrile seizures plus spectrum

Summary

Genetic epilepsy with febrile seizures plus spectrum (MONDO:0800489) is a disease. A subtype of neonatal/infantile-onset self-limited epilepsy syndrome — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	genetic epilepsy with febrile seizures plus spectrum
Mondo ID	MONDO:0800489
GARD	0027297
Is cancer (heuristic)	no

Also known as: GEFS+

Disease family

Classification path: disease › human disease › disease by body system or component › nervous system disorder › central nervous system disorder › brain disorder › epilepsy › epilepsy syndrome › neonatal/infantile epilepsy syndrome › neonatal/infantile-onset self-limited epilepsy syndrome › genetic epilepsy with febrile seizures plus spectrum

Related subtypes (4): self-limited familial infantile epilepsy, self-limited familial neonatal-infantile epilepsy, myoclonic epilepsy in infancy, self-limited neonatal seizures

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 0.